Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU513400B2 - Biodegradable, sustained release composition - Google Patents
[go: Go Back, main page]

AU513400B2 - Biodegradable, sustained release composition - Google Patents

Biodegradable, sustained release composition

Info

Publication number
AU513400B2
AU513400B2 AU22958/77A AU2295877A AU513400B2 AU 513400 B2 AU513400 B2 AU 513400B2 AU 22958/77 A AU22958/77 A AU 22958/77A AU 2295877 A AU2295877 A AU 2295877A AU 513400 B2 AU513400 B2 AU 513400B2
Authority
AU
Australia
Prior art keywords
biodegradable
sustained release
release composition
composition
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU22958/77A
Other versions
AU2295877A (en
Inventor
H. M Chandler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
Commonwealth Serum Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Serum Laboratories filed Critical Commonwealth Serum Laboratories
Publication of AU2295877A publication Critical patent/AU2295877A/en
Application granted granted Critical
Publication of AU513400B2 publication Critical patent/AU513400B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU22958/77A 1976-03-04 1976-03-04 Biodegradable, sustained release composition Expired AU513400B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPC510876 1976-03-04

Publications (2)

Publication Number Publication Date
AU2295877A AU2295877A (en) 1978-09-07
AU513400B2 true AU513400B2 (en) 1980-11-27

Family

ID=3766563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22958/77A Expired AU513400B2 (en) 1976-03-04 1976-03-04 Biodegradable, sustained release composition

Country Status (7)

Country Link
JP (1) JPS52125613A (en)
AU (1) AU513400B2 (en)
CA (1) CA1084413A (en)
DE (1) DE2709488A1 (en)
FR (1) FR2342741A1 (en)
GB (1) GB1567503A (en)
NZ (1) NZ183458A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54126648U (en) * 1978-02-24 1979-09-04
JPS54127551U (en) * 1978-02-25 1979-09-05
CA1143289A (en) * 1978-10-17 1983-03-22 Lee R. Beck Microparticle drug delivery system
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
JPS6089418A (en) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd Sustained release carcinostatic agent
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
DE3500268A1 (en) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt PREPARATIONS WITH DELAYED EFFECT, METHOD FOR THE PRODUCTION THEREOF AND CORRESPONDING AGENTS FOR THE HUMAN OR. VETERINE MEDICAL APPLICATION
IL78826A (en) * 1986-05-19 1991-05-12 Yissum Res Dev Co Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
JPWO2008072379A1 (en) * 2006-12-13 2010-03-25 富士フイルム株式会社 Method for producing modified biopolymer and method for cross-linking biopolymer
JP5047603B2 (en) * 2006-12-15 2012-10-10 エア・ウォーター株式会社 Gelatin molding and method for producing the same

Also Published As

Publication number Publication date
GB1567503A (en) 1980-05-14
AU2295877A (en) 1978-09-07
DE2709488A1 (en) 1977-10-27
FR2342741A1 (en) 1977-09-30
NZ183458A (en) 1979-10-25
JPS52125613A (en) 1977-10-21
CA1084413A (en) 1980-08-26

Similar Documents

Publication Publication Date Title
AU516497B2 (en) Polyanionic polyamides as deodorants
AU505080B2 (en) 2-piperazinyl-6, 7-dimethoxyquinazolines
AU2866477A (en) Isocyanate-prepolymer composition
AU506640B2 (en) APH-indicator composition
AU505445B2 (en) Polymerisable composition
AU505355B2 (en) Sustained release formulation
AU510212B2 (en) 1-diamino-oxytocin compositions
AU513400B2 (en) Biodegradable, sustained release composition
AU516060B2 (en) Sterolin compositions
AU515306B2 (en) Release sheet
AU508007B2 (en) 1, 5-Disubstituted-2-Pyrrolidones
AU2668177A (en) 2, 6-Methano-2H-l-Benzoxocins
AU507991B2 (en) Poly (phoshapazene) composition
AU512313B2 (en) y, y, Disubstituted-5-valerolactones
AU500386B2 (en) 1,2,6-thidiazinones
AU2546577A (en) 5, 5-trimethylhexanoyl-ferrocene
AU514573B2 (en) Compositions
AU2966277A (en) Polyanionic polyamides as deodorants
AU511482B2 (en) 1-amino-lower alkyl-3, 4-diphenyl-1h-pyrazoles
AU511827B2 (en) 5-anyl-3, 6-dihydro-l, 3, 4-oxadiazin-2-ones
AU512477B2 (en) Glass-size composition
AU506922B2 (en) N-6-chlorunicotinoyl-d, l-homocysteing thiolactonne
AU510146B2 (en) Trawl-net catch release
AU505128B2 (en) Copolymer composition
AU2242877A (en) 5,6-dehydropenicillins